IIM
TSHA icon

INTECH Investment Management’s Taysha Gene Therapies TSHA Stock Holding History

INTECH Investment Management’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$215K Sell
47,988
-23,081
-32% -$107K ﹤0.01% 1724
2025
Q4 		$391K Buy
71,069
+2,443
+4% +$11.9K ﹤0.01% 1625
2025
Q3 		$224K Sell
68,626
-13,569
-17% -$38.4K ﹤0.01% 1995
2025
Q2 		$190K Sell
82,195
-17,717
-18% -$38.5K ﹤0.01% 2109
2025
Q1 		$139K Buy
99,912
+31,877
+47% +$53.3K ﹤0.01% 2219
2024
Q4 		$118K Buy
68,035
+25,941
+62% +$53.8K ﹤0.01% 2179
2024
Q3 		$84.6K Buy
+42,094
New +$92.4K ﹤0.01% 1916

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM